Hospital Acquired Infection Control Market Size, Share and Growth Outlook, 2026

Hospital Acquired Infection Control Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Hospital Acquired Infection Control Market size is forecast to increase from $8.77 Billion in 2026 to $16.72 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

The Hospital Acquired Infection Control market report provides detailed analysis and outlook of Hospital Acquired Infection Control segments including By Component (Consumables, Equipment, Services), By Infection Control Practice (Hand Hygiene Management, Surface Disinfection, Instrument Sterilization, Personal Protective Equipment Usage, Environmental Monitoring), By Technology (Sterilization Technology, Disinfection Technology), By Infection Type (Surgical Site Infections, Urinary Tract Infections, Bloodstream Infections, Hospital-Acquired Pneumonia, Gastrointestinal Infections), By End User (Hospitals & Intensive Care Units, Ambulatory Surgical Centers, Clinics & Specialty Centers, Long-Term Care Facilities) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Hospital Acquired Infection Control Industry Overview

Increasing Focus on Healthcare-Associated Infection Prevention

The hospital acquired infection control industry remains a critical component of modern healthcare systems as hospitals prioritize patient safety, regulatory compliance, and quality improvement initiatives. Healthcare-associated infections continue to represent significant clinical and operational challenges, driving healthcare providers to adopt advanced infection prevention strategies. Hospitals are increasingly investing in surveillance technologies, environmental disinfection solutions, and evidence-based hygiene protocols to reduce infection transmission risks. The growing emphasis on measurable patient outcomes and value-based healthcare models is further accelerating demand for comprehensive infection control programs across acute care, pediatric, and long-term care facilities.

National Infection Reduction Trends Supporting Market Growth

Recent nationwide healthcare surveillance data demonstrate the effectiveness of standardized infection prevention measures. The latest National Healthcare-Associated Infections Progress Report from the Centers for Disease Control and Prevention highlighted meaningful reductions in key infection indicators across healthcare facilities. The report documented a 9% decline in Central Line-Associated Bloodstream Infections (CLABSIs) and an 11% reduction in hospital-onset Clostridioides difficile infections. These improvements validate the impact of standardized hygiene mandates, infection monitoring programs, and clinical best practices. Continued progress in reducing infection rates is encouraging healthcare organizations to expand investments in technologies and operational frameworks that support sustained infection prevention performance.

Value-Based Care Policies Driving Infection Control Investments

Regulatory and reimbursement frameworks are increasingly shaping infection control strategies throughout the healthcare sector. The Centers for Medicare & Medicaid Services finalized implementation guidelines for the Fiscal Year 2026 Hospital-Acquired Condition Reduction Program, which evaluates general acute care hospitals using a combination of CDC infection metrics and the CMS PSI 90 index. Under this value-based purchasing model, hospitals ranking within the lowest-performing 25% face a mandatory 1% reduction in Medicare fee-for-service reimbursement payments. This financial accountability mechanism is encouraging healthcare providers to strengthen infection prevention programs, improve compliance with clinical protocols, and adopt technologies capable of delivering measurable reductions in hospital-acquired conditions.

Automation and Artificial Intelligence Transforming Infection Surveillance

Healthcare systems are increasingly deploying advanced digital solutions to strengthen infection control capabilities and avoid performance-related financial penalties. Multi-state hospital networks have accelerated implementation of continuous automated infection surveillance software integrated with touchless decontamination technologies. These systems utilize predictive artificial intelligence embedded within Electronic Health Records to identify potential contagion pathways and assess infection risks in real time. The generated insights guide robotic ultraviolet-C (UV-C) disinfection units and hydrogen peroxide vapor systems to sanitize high-touch surfaces throughout intensive care units and other critical care environments. The convergence of artificial intelligence, automated environmental cleaning, and real-time surveillance is creating a more proactive and data-driven approach to hospital acquired infection control.

Hospital Acquired Infection Control Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Hospital Acquired Infection Control market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- 3M Company, STERIS plc, Getinge AB, Ecolab Inc., Cantel Medical (STERIS), Advanced Sterilization Products (Fortive/ASP), Belimed AG (Metall Zug Group), Matahcana Group, Cardinal Health, Inc., Olympus Corporation. The Hospital Acquired Infection Control market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Hospital Acquired Infection Control industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Hospital Acquired Infection Control Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Hospital Acquired Infection Control companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Hospital Acquired Infection Control markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Hospital Acquired Infection Control Market Competitive Benchmarking and Company Analysis

Leading companies in Hospital Acquired Infection Control industry include- 3M Company, STERIS plc, Getinge AB, Ecolab Inc., Cantel Medical (STERIS), Advanced Sterilization Products (Fortive/ASP), Belimed AG (Metall Zug Group), Matahcana Group, Cardinal Health, Inc., Olympus Corporation. The Hospital Acquired Infection Control market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Hospital Acquired Infection Control Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Hospital Acquired Infection Control market remains one of the strongest-performing segments in the country.
The US Hospital Acquired Infection Control Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Hospital Acquired Infection Control market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Hospital Acquired Infection Control industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Hospital Acquired Infection Control markets

Canada's strong Hospital Acquired Infection Control sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Hospital Acquired Infection Control market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Hospital Acquired Infection Control Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Hospital Acquired Infection Control market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Hospital Acquired Infection Control population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Hospital Acquired Infection Control industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Hospital Acquired Infection Control market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Hospital Acquired Infection Control sales through 2034

France Hospital Acquired Infection Control companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Hospital Acquired Infection Control Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Hospital Acquired Infection Control distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Hospital Acquired Infection Control Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Hospital Acquired Infection Control market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Hospital Acquired Infection Control industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Hospital Acquired Infection Control industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Hospital Acquired Infection Control Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Hospital Acquired Infection Control market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Hospital Acquired Infection Control market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Hospital Acquired Infection Control Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Hospital Acquired Infection Control Market Segmentation

By Component
Consumables
Equipment
Services
By Infection Control Practice
Hand Hygiene Management
Surface Disinfection
Instrument Sterilization
Personal Protective Equipment Usage
Environmental Monitoring
By Technology
Sterilization Technology
Disinfection Technology
By Infection Type
Surgical Site Infections
Urinary Tract Infections
Bloodstream Infections
Hospital-Acquired Pneumonia
Gastrointestinal Infections
By End User
Hospitals & Intensive Care Units
Ambulatory Surgical Centers
Clinics & Specialty Centers
Long-Term Care Facilities

Top Companies in Hospital Acquired Infection Control Industry

3M Company
STERIS plc
Getinge AB
Ecolab Inc.
Cantel Medical (STERIS)
Advanced Sterilization Products (Fortive/ASP)
Belimed AG (Metall Zug Group)
Matahcana Group
Cardinal Health, Inc.
Olympus Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025